ahlam1399
03-25-2016, 06:00 PM
FDA staff backs Acadia?s drug to treat psychosis associated with Parkinson?s disease
March 25 (Reuters) - U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc's drug to treat psychosis associated with Parkinson's disease was effective e**ugh to warrant approval.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e8267c5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=mH3AZ-525cY:P3thntlxi3s:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=mH3AZ-525cY:P3thntlxi3s:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/mH3AZ-525cY
March 25 (Reuters) - U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc's drug to treat psychosis associated with Parkinson's disease was effective e**ugh to warrant approval.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e8267c5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=mH3AZ-525cY:P3thntlxi3s:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=mH3AZ-525cY:P3thntlxi3s:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=mH3AZ-525cY:P3thntlxi3s:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/mH3AZ-525cY